The Relationship Between ICS LABA Administration and Blood Eosinophil Levels in COPD Patient at USU General Hospital

Olivia Monica Deneuve; Andika Pradana; Amira P Tarigan

doi:10.47353/jsocmed.v3i12.180

The Relationship Between ICS LABA Administration and Blood Eosinophil Levels in COPD Patient at USU General Hospital

Olivia Monica Deneuve
Department of Pulmonology and Respiratory Medicine, Faculty of Medicine Universitas Sumatera Utara, Adam Malik General Hospital, Medan Indonesia
Andika Pradana
Department of Pulmonology and Respiratory Medicine, Faculty of Medicine, Universitas Sumatera Utara, Universitas Sumatera Utara General Hospital, Medan, Indonesia.
Amira P Tarigan
Department of Pulmonology and Respiratory Medicine, Faculty of Medicine, Universitas Sumatera Utara, Universitas Sumatera Utara General Hospital, Medan, Indonesia

Abstract

Introduction: Blood eosinophil count may predict treatment response in patients with chronic obstructive pulmonary disease (COPD) during acute exacerbations. However, the ability of blood eosinophil counts in stable status to predict eosinophilic.

Method: This was a cohort retrospective study performed Juni-August 2022 to Juni-August 2023. Subject were COPD patients who were treated at the outpatient using ICS LABA therapy. Blood samples measured blood eosinophil levels first and control.

Results: Based on Wilcoxon test test, there was a significant positive positive correlation of eosinophil counts between ICS LABA Administration and Blood Eosinophil Levels in COPD Patient at USU General Hospital.

Conclusion: We demonstrated association between ICS LABA Administration and Blood Eosinophil Levels in COPD Patient (p value = 0.02).

Similar Articles

Batian Lubis, Dis Bima P Purwaamidjaja, Mayang Indah Lestari, Faisal, Muhammad Husni Thamrin, Febri Akhmad Belinda, A Case Series of Bleeding Complication Post Percutaneous Dilatational Tracheostomy and Management , Journal of Society Medicine: Vol. 2 No. 12 (2023): December
Kadek Adi Sudarmika, Ni Luh Eka Sriayu Wulandari, Dilated Cardiomyopathy Related to Hyperthyroidism in Young Adults , Journal of Society Medicine: Vol. 3 No. 8 (2024): August
Mukhamad Faried, Franciscus Ginting, Tambar Kembaren, Putri Chairani Eyanoer, Factor Influencing Mortality in Moderate - Severe Covid-19 Patients In Tertiary Hospital, Indonesia , Journal of Society Medicine: Vol. 2 No. 7 (2023): July
Dian Primadia Putri, Rahmad Isnanta Sembiring, Tambar Kembaren, Putri Eyanoer, Relationship of D-dimer Value to Mortality in Covid-19 Patients with Acute Coronary Syndrome at Haji Adam Malik Hospital Medan , Journal of Society Medicine: Vol. 2 No. 4 (2023): April
Nelly Rosdiana, Novia Kemal , Lactate Dehydrogenase and Blast Rates in the Diagnostic Phase and the Late Remission Phase of Acute Childhood Leukaemia Patients , Journal of Society Medicine: Vol. 3 No. 8 (2024): August
T. Rifqi Hashmi, Harris Hasan, Hilfan Ade Putra Lubis, The Relationship between LDL/ HDL Ratio and Coronary Lesion Severity Measured by Syntax Score in Patients with Non-Elevation Acute Myocardial Infarction at Hajj Adam Malik General Hospital, Medan , Journal of Society Medicine: Vol. 3 No. 5 (2024): May
M. Randy Harry, Elvita Rahmi Daulay, Radar Radius Tarigan, Correlation of Kidney Volume on CT-Scan with Kidney Function Tests in Patients with Normal Kidneys at Haji Adam Malik Hospital Medan in 2020-2021 , Journal of Society Medicine: Vol. 2 No. 4 (2023): April
Intan Fachrina, Syamsul Bihar, Fajrinur Syarani, Correlation of Bronchoscopy Visualization With Cell Type in Lung Cancer Patients at Haji Adam Malik Hospital Medan 2023 , Journal of Society Medicine: Vol. 3 No. 10 (2024): Oktober
Annisa Nidya Rahmatika Sitepu, Dharma Lindarto, Melati Silvanni Nasution, Lipid Profile in Confirmed Covid-19 Patients with Type 2 Diabetes Mellitus At Haji Adam Malik General Hospital Medan from March 2020 to December 2021 , Journal of Society Medicine: Vol. 2 No. 3 (2023): March
Muhammad Ferhat E.S, Zainal Safri, Yuke Sarastri, Interleukin-6 Reduction as a Predictor of Functional Capacity Improvement after Phase II Cardiac Rehabilitation Programme in Coronary Artery Bypass Surgery Patients , Journal of Society Medicine: Vol. 3 No. 2 (2024): February

<< < 1 2 3 4 5 6 7 8 9 10 > >>

You may also start an advanced similarity search for this article.

PDF

Published at

31. December 2024
https://doi.org/10.47353/jsocmed.v3i12.180
Issue:

Vol. 3 No. 12 (2024): December
Section:

Articles
Keywords:

Blood, Eosinophilia Exacerbation COPD (Chronic Obstructive Pulmonary Disease) GOLD
References:

Mathers CD, Loncar D. Projections of global mortality and burden of disease. PLoS Med 2006; 11: 4-42.

Chen W, Thomas J, Sadatsafavi M, FitzGerald JM. Risk of cardiovascular comorbidity in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. Lancet Respir Med. 2015; 8: 9-631.

Pascoe S, Locantore N, Dransfield MT, Barnes NC, Pavord ID. Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials. Lancet Respir Med. 2015; 6: 42-435.

Bafadhel M, Peterson S, De Blas MA, Singh D, Calverley PMA, Pavord ID, et al. Predictors of exacerbation risk and response to budesonide in patients with chronic obstructive pulmonary disease: a post-hoc analysis of three randomised trials. Lancet Respir Med. 2018; 2: 26-117.

Hartl S, Breyer MK, Burghuber OC, Hacker S, Schrott A, Rudzicki W, et al. Blood eosinophil count in the general population: typical values and potential confounders. Eur Respir J. 2020; 5: 874-1901.

Kolsum U, Southworth T, Jackson N, Singh D. Blood eosinophil counts in COPD patients compared to controls. Eur Respir J. 2019; 4: 633-1900.

Celli B, Fabbri L, Criner G, Wedzicha JA, Martinez FJ, Agusti A, et al. Definition and nomenclature of chronic obstructive pulmonary disease: time for its revision. Am J Respir Crit Care Med. 2022; 205: 1-20.

Agusti A, Melen E, DeMeo DL, Breyer-Kohansal R, Faner R, Wouters EF, et al. Pathogenesis of chronic obstructive pulmonary disease: understanding the contributions of gene-environment interactions across the lifespan. Lancet Respir Med. 2022; 5: 24-512.

Yang IA, Jenkins CR, Salvi SS. Chronic obstructive pulmonary disease in never-smokers: risk factors, pathogenesis, and implications for prevention and treatment. Lancet Respir Med. 2022; 5: 497-511.

Cho MH, Hobbs BD, Silverman EK. Genetics of chronic obstructive pulmonary disease: understanding the pathobiology and heterogeneity of a complex disorder. Lancet Respir Med. 2022; 5: 96-485.

Bardsen T, Roksund OD, Benestad MR, Clemm HH, Halvorsen T, Røksund AB, Markestad T. Tracking of lung function from 10 to 35 years after being born extremely preterm or with extremely low birth weight. Thorax. 2022; 8: 8-790.

Eisner MD, Anthonisen N, Coultas D, Perez-Padilla R, Buist S, Mannino D, et al. An official American Thoracic Society public policy statement: novel risk factors and the global burden of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2010; 15: 693-718.

Li J, Sun S, Tang R, Qiu H, Wang W, Yan L, et al. Major air pollutants and risk of COPD exacerbations: a systematic review and meta-analysis. Int J Chron Obstruct Pulmon Dis. 2016; 11: 91-3079.

Erry P. Korelasi antara eosinofil darah dan sputum pasien penyakit paru obstruksi kronik (PPOK) di Rumah Sakit Rujukan Respirasi Nasional Persahabatan. Jakarta. 2019; 1: 1-50.

Shibata Y. Role of ICS/LABA on COPD treatment. Japan. 2016; 1: 1-30.

Babu KS, Kastelik JA, Morjaria JB. Inhaled corticosteroid in chronic obstructive pulmonary disease. J Chron Obstruct Pulmon Dis. 2014; 4: 137-821.
Share:

Z

Deneuve, O. M., Pradana, A., & Tarigan, A. P. (2024). The Relationship Between ICS LABA Administration and Blood Eosinophil Levels in COPD Patient at USU General Hospital. Journal of Society Medicine, 3(12), 374–378. https://doi.org/10.47353/jsocmed.v3i12.180